Healthcare
NewAmsterdam Pharma Company N.V.
NAMS$25.34-2.16%
Price is delayed.
Add to Watchlist
About NewAmsterdam Pharma Company N.V.
NewAmsterdam Pharma is a drug company working on treatments for heart disease and related conditions. The company is developing a pill called Obicetrapib that lowers cholesterol in the blood, which can help prevent heart attacks and strokes. They are also testing this same drug as a potential treatment for Alzheimer's disease. The company is based in the Netherlands.
Loading chart...
Members only
Full research is for ConvictionStocks members
Members read the rest of this page. Where we have it for this company, that is:
- What each number means, in plain English, with the Wall Street name where the two differ.
- A plain-English summary of the company.
- How many analysts cover it, and the count behind each rating.
- Recent news, dated.
Get the free weekly market digest
The week's biggest movers, every Sunday. No spam.
Look up another company
Related Research
More Healthcare stocks to explore